Physician

Audrey Ko, M.D.

According to 2025 Medicare claims, Audrey Ko, M.D. (NPI: 1891089546) practices ophthalmology in the Des Moines-West Des Moines, IA market, with the plurality of this provider's patient population coming from Polk, IA. This provider's primary affiliated billing organization is THRIVE HEALTH IV CLINIC, P.C. (NPI: 1184314171) and primary practice location at 50266-7755.

Ko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 706 traditional Medicare patients, billed 10,458 HCPCS/CPT codes, and received $866,771 in Medicare payments. The top billing code was 15823 (Removal of excessive skin and fat of upper eyelid). Part D data shows 599 prescription claims across 477 beneficiaries totaling $10,162 in drug costs, led by Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha). Open Payments data shows 42 records totaling $18,215. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,764 to $866,771. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,936 to $10,162. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$433K$867K2016 Medicare payment: $3,764 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $26,786 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $115,863 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $90,252 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $188,333 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $234,094 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $278,479 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $320,123 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $866,771 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20165154$3,764
2017101214$26,786
2018291794$115,863
2019219675$90,252
20204202,759$188,333
20214804,471$234,094
20225876,122$278,479
20236348,186$320,123
202470610,458$866,771

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.1K$10K2015 Drug cost: $3,936 (USD; Tot_Drug_Cst)2016 Drug cost: $1,769 (USD; Tot_Drug_Cst)2017 Drug cost: $1,757 (USD; Tot_Drug_Cst)2018 Drug cost: $918 (USD; Tot_Drug_Cst)2019 Drug cost: $4,382 (USD; Tot_Drug_Cst)2020 Drug cost: $4,779 (USD; Tot_Drug_Cst)2021 Drug cost: $5,845 (USD; Tot_Drug_Cst)2022 Drug cost: $10,021 (USD; Tot_Drug_Cst)2023 Drug cost: $6,520 (USD; Tot_Drug_Cst)2024 Drug cost: $10,162 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201532121$3,936
20166083$1,769
20175168$1,757
20185269$918
201974110$4,382
2020231316$4,779
2021287365$5,845
2022372486$10,021
2023392479$6,520
2024477599$10,162

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
15823Removal of excessive skin and fat of upper eyelid154154$584
67900Repair of brow paralysis139139$271
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more219219$111
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more288331$85
92081Exam of visual field with limited testing248252$23

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha4233,397$3,946
ErythromycinErythromycin Base90837$845
ValacyclovirValacyclovir Hcl13169$486
Doxycycline MonohydrateDoxycycline Monohydrate23343$247
PrednisonePrednisone18418$101

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.41$18,215Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$28,214US Retina LLC

FAQ

What Medicare data is available for Audrey Ko, M.D.?

Tedicare shows public-source Medicare data for Audrey Ko, M.D. (NPI 1891089546), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Audrey Ko, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Audrey Ko, M.D.?

Audrey Ko, M.D. is linked to THRIVE HEALTH IV CLINIC, P.C. (billing NPI 1184314171) in the available physician profile data.

Does Audrey Ko, M.D. have Open Payments data?

Audrey Ko, M.D. has 42 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.